Professor of Surgery, McGill Division of Orthopedic Surgery
McGill University Health Centre, Canada
Dr Turcotte is the medical director of the designated supraregional sarcoma program at MUHC and an affiliated member of the MUHC Department of Oncology. His tumor works serve both children and adults. Dr Turcotte has been involved at different levels within the Canadian Orthopaedic Association (COA) and the Quebec Orthopaedic Association (QOA), which he served as president from 2014-2018. He sits on the executive of the sarcoma branch of the National Cancer Trial Group of Canada and he was the spoke person for oncology within the COA for many years. He’s currently chair the outcome section of the Canadian Orthopaedic Oncology Society (CanOOS) and sit on the steering committee of the recently created Canadian Sarcoma Clinical and Research Collaboration (CanSarCC). Additionally he is a member of many national and international musculoskeletal oncology societies and sits on different committees. Dr Turcotte has been involved in the organization of many national and international meetings. His activities have led to many lectures, publications and professorships. He is an ad hoc reviewer for many journals and has served on editorial boards of orthopaedic journals. He also led or joined many national and international collaborative efforts on clinical research. His interest in bone banking and tissue transplantation lead him to sit on the Quebec Biovigilance committee and the Canadian Council for Donation and Transplantation (CCDT). He also participated to the establishment of a national surveillance system on adverse events following tissue transplantation with the Public Health Agency of Canada (PHAC). His work has been recognized through many awards including, the COA award of merit and the Lloyd McLean award which have given him the opportunity to do a scholarship at Instituto Orthopedico Rizzoli in Bologna. He was admitted as Member of Honor by the French Orthopedic Society (SoFCOT) in 2016.